TY  - JOUR
AU  - Ruiz-Casas, Leonardo
AU  - Pedra, Gabriel
AU  - Shaikh, Anum
AU  - Franks, Bethany
AU  - Dhillon, Harpal
AU  - Fernandes, João Diogo da Rocha
AU  - Mangla, Kamal Kant
AU  - Augusto, Margarida
AU  - Schattenberg, Jörn M
AU  - Romero-Gómez, Manuel
PY  - 2021
DO  - 10.1097/MD.0000000000028165
UR  - https://hdl.handle.net/10668/27176
T2  - Medicine
AB  - One fifth of patients with nonalcoholic fatty liver disease (NAFLD) may progress to nonalcoholic steatohepatitis (NASH), which can increase the risk of cirrhosis, cancer, and death. To date, reported predictors of NASH progression have been...
LA  - en
KW  - Aged
KW  - Biopsy
KW  - Disease Progression
KW  - Female
KW  - Fibrosis
KW  - Humans
KW  - Liver
KW  - Liver Cirrhosis
KW  - Male
KW  - Middle Aged
KW  - Non-alcoholic Fatty Liver Disease
KW  - Obesity
KW  - Social Determinants of Health
KW  - United States
TI  - Clinical and sociodemographic determinants of disease progression in patients with nonalcoholic steatohepatitis in the United States.
TY  - research article
VL  - 100
ER  -